Cannabinoids are a broad class of chemical compounds that interact with a specific network of receptors found throughout your body. Some are produced naturally by your own cells, some come from the cannabis plant, and others are made in a lab. What ties them together is their ability to plug into the same biological system, influencing everything from pain and mood to appetite and immune function.
The Three Types of Cannabinoids
Cannabinoids fall into three categories based on where they come from. Endocannabinoids are made by your own body. Phytocannabinoids come from plants, primarily cannabis. Synthetic cannabinoids are engineered in laboratories to mimic the effects of the first two groups.
These categories matter because origin shapes how each type behaves. Your body’s own cannabinoids are produced on demand and broken down quickly. Plant cannabinoids are longer-lasting and vary in potency depending on the specific compound. Synthetic versions can be far more powerful and unpredictable, which is why they carry a significantly higher risk of harm.
Your Body’s Built-In Cannabinoid System
Your body runs its own cannabinoid network called the endocannabinoid system. It uses two main signaling molecules: anandamide and 2-AG. These are fatty compounds your cells produce as needed to fine-tune processes like pain signaling, inflammation, stress response, and appetite. Once they’ve done their job, an enzyme called FAAH breaks them down so their effects don’t linger.
These molecules work by binding to two types of receptors. CB1 receptors are concentrated heavily in the brain, which is why cannabinoids can affect mood, memory, coordination, and perception. CB2 receptors are found mainly on immune cells and play a role in regulating inflammation. This two-receptor system explains why cannabinoids can have such wide-ranging effects across both the nervous and immune systems.
The endocannabinoid system essentially acts as a dimmer switch, dialing biological responses up or down to keep things in balance. When outside cannabinoids enter your body, whether from a plant or a pill, they interact with these same receptors and override or extend the signals your body would normally produce briefly on its own.
Cannabinoids From the Cannabis Plant
The cannabis plant produces over 100 different cannabinoids, but two dominate the conversation: THC and CBD. THC binds directly to CB1 receptors in the brain, which is what produces the “high” associated with marijuana. It also stimulates appetite, reduces nausea, and alters pain perception.
CBD works differently. It has low binding affinity for CB1 and CB2 receptors and does not produce intoxication. Instead, it appears to influence the endocannabinoid system indirectly, and it interacts with several other receptor systems involved in pain, anxiety, and seizure activity. This distinction is why CBD has gained traction as a therapeutic compound separate from recreational cannabis use.
A third phytocannabinoid gaining attention is CBG (cannabigerol). It acts as a weak activator of CB1 receptors and a partial activator of CB2 receptors, meaning its direct cannabinoid effects are mild. CBG’s more notable activity happens outside the cannabinoid system: it interacts with pain-sensing channels, inflammation pathways, and enzymes involved in immune signaling. Early research suggests potential roles in reducing inflammation and addressing pain, though clinical evidence in humans remains limited.
Synthetic Cannabinoids and Their Risks
Synthetic cannabinoids are lab-made chemicals designed to activate the same receptors as THC. They first appeared in research settings in the 1990s and later showed up in products sold as “herbal incense” or “spice.” The critical difference is potency: most synthetic cannabinoids bind to CB1 receptors with significantly higher affinity than THC. Where THC has a binding affinity of about 40.7 nanomolar, many synthetics bind far more tightly, producing effects that are stronger and harder to control.
This higher potency translates to greater danger. Synthetic cannabinoids are associated with much more serious harm and higher rates of death than plant-derived cannabinoids. Effects can include severe agitation, seizures, rapid heart rate, psychosis, and kidney damage. Because these compounds are manufactured without standardization, the dose in any given product is unpredictable.
How Cannabinoids Enter Your Body
The way you take a cannabinoid dramatically changes how much actually reaches your bloodstream and how quickly you feel its effects. Inhaling (smoking or vaping) delivers roughly 31% of the compound into circulation, with effects beginning within minutes. Oral ingestion, such as edibles or capsules, has much lower bioavailability, estimated at 13 to 19% for CBD, because the compound is partially broken down by your liver before it ever reaches general circulation. This is why edibles take longer to kick in (often 30 to 90 minutes) and why people sometimes take too much while waiting to feel something.
Sublingual delivery, where drops are held under the tongue, falls somewhere in between. It bypasses some of that liver processing but produces relatively low peak blood levels. The practical takeaway: inhalation hits fastest and delivers the most, oral routes are slower and less efficient, and sublingual sits in the middle.
FDA-Approved Cannabinoid Medications
The FDA has not approved cannabis itself for any medical condition, but it has approved four cannabinoid-based medications. Epidiolex is a purified CBD product approved for treating seizures in two severe forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome) in patients two years and older. Marinol and Syndros both contain a synthetic version of THC and are prescribed for chemotherapy-related nausea and appetite loss in AIDS patients. Cesamet contains a THC-like synthetic compound approved for chemotherapy nausea.
These approvals are narrow. The vast majority of cannabinoid products sold in dispensaries and health stores have not gone through FDA review, and their contents and dosing can vary widely.
The Entourage Effect
One idea that comes up frequently in cannabis discussions is the “entourage effect,” the theory that cannabinoids work better together than in isolation. The concept suggests that the full mix of cannabinoids, terpenes (aromatic compounds), and flavonoids in whole-plant cannabis produces stronger therapeutic outcomes than any single purified compound.
Many patients report better results with full-spectrum products compared to isolated THC or CBD, and there is some laboratory evidence showing interactions between these compounds. Two types of synergy have been proposed: interactions among cannabinoids themselves and interactions between cannabinoids and terpenes. However, the clinical evidence remains thin. Some combinations that look promising in test tubes, like CBD paired with the terpene myrcene for inflammation, haven’t shown significant additional benefit in more rigorous testing. Critics argue the term is used more as a marketing concept than a scientifically validated principle. The reality is likely somewhere in between: some synergy probably exists, but its magnitude and clinical relevance are still being worked out.
Short-Term and Long-Term Effects
In the short term, cannabinoids (particularly THC) cause elevated heart rate, reduced blood pressure, bloodshot eyes, impaired coordination, slower reaction times, and decreased concentration. These effects are rarely life-threatening in adults using plant-derived products, though they can impair driving and decision-making. Children are more vulnerable: accidental cannabis ingestion in kids can cause significant lethargy, loss of muscle coordination, seizures, and in serious cases, a reduced level of consciousness.
With prolonged, heavy use, the picture shifts. Chronic effects include lung irritation from smoking, increased cardiovascular risk, reduced fertility, and measurable deficits in memory and cognitive function. One condition unique to heavy, long-term cannabis users is cannabinoid hyperemesis syndrome, a cycle of severe vomiting that, counterintuitively, tends to be relieved by hot showers. It resolves when cannabis use stops. As marijuana laws have loosened across the U.S., cases of this syndrome have become more common.